Freedman Financial Associates’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-58
Closed -$2K 10
2022
Q1
$2K Hold
58
﹤0.01% 451
2021
Q4
$3K Hold
58
﹤0.01% 410
2021
Q3
$2K Hold
58
﹤0.01% 436
2021
Q2
$3K Buy
+58
New +$2.71K ﹤0.01% 408

Other funds holding ADNT

Freedman Financial Associates's ADNT Position: Q2 2022 in Review

Freedman Financial Associates sold out of Adient (ADNT) in Q2 2022, closing a stake of 58 shares — an estimated $2K sold.

Freedman Financial Associates first reported a position in ADNT in Q2 2021 and held it in 4 quarters. The position peaked at $3K in Q4 2021. 258 funds tracked by Wall St. Rank hold ADNT as of Q2 2022.

  • Freedman Financial Associates reported no remaining Adient position as of Q2 2022 after selling out during the quarter.
  • Freedman Financial Associates sold 58 Adient shares in Q2 2022, an estimated $2K.
  • Freedman Financial Associates first reported a position in Adient in Q2 2021 and held it in 4 quarters.
  • Freedman Financial Associates's Adient position peaked at $3K in Q4 2021.
  • 258 funds tracked by Wall St. Rank held Adient as of Q2 2022.

Based on Freedman Financial Associates's 13F filing for Q2 2022.